Skip to main content

Table 1 Patients switched to ETV with an undetectable viral load

From: Etravirine use in clinical practice: 48-week data from a single centre cohort

VL< 50 copies/ml 12 weeks (n = 36) 24 weeks (n = 24) 36 weeks (n = 17) 48 weeks (n = 8)
Intention to treat 100% 88% 94% 88%
On treatment 100% 91% 100% 100%